Immunotherapy in Sarcoma: Current Data and Promising Strategies
GE Wood, C Meyer, F Petitprez… - American Society of …, 2024 - ascopubs.org
Traditionally sarcomas have been considered immunologically quiet tumours, with low
tumour mutational burden (TMB) and an immunosuppressive tumour microenvironment …
tumour mutational burden (TMB) and an immunosuppressive tumour microenvironment …
Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics
JW Magrath, M Espinosa-Cotton… - Frontiers in Cell and …, 2024 - frontiersin.org
Desmoplastic Small Round Cell Tumor (DSRCT) is a highly aggressive pediatric cancer
caused by a reciprocal translocation between chromosomes 11 and 22, leading to the …
caused by a reciprocal translocation between chromosomes 11 and 22, leading to the …
Biomarkers to predict the benefits of immune‑checkpoint blockade‑based therapy in patients with malignant peritoneal mesothelioma
C Wang, Y Zhao, W Liang - Oncology Letters, 2024 - spandidos-publications.com
Malignant peritoneal mesothelioma (MPeM) is a type of rare and highly lethal tumor.
Immune checkpoint blockade (ICB)-based therapy has shown encouraging clinical activity …
Immune checkpoint blockade (ICB)-based therapy has shown encouraging clinical activity …